Filing Flows

Filing Flows › Celanese (CE) › Q3 2026 › vs Q3 2025

Celanese (CE) Q3 2026 vs Q3 2025 (year over year)

Celanese's revenue rose $137M (+6%) from $2.4B in Q3 2025 to $2.6B in Q3 2026. The biggest changes: Acetyl Chain +$153M (+15%); Engineered Materials −$16.0M (-1%). Gross margin 21.1% against 21.5% (-0.5 pts).

Celanese, Q3 2026: revenue $2.6B (+6% year over year), operating margin 7.7%, net earnings $74.0M, operating cash flow $538M. The chart draws each line against Q3 2025, the increases inside each band.

Celanese: what changed, Q3 2026 vs Q3 2025Celanese: what changed, Q3 2026 vs Q3 2025Operating profit$1.5BOther operating costs−$1.5BOperating expenses−$1.5BPre-tax earnings$1.5BNet earnings$1.4BWorking capital & other−$1.4BAcetyl Chain$153MCost of revenue$119MOperating cash flow$91.0MFree cash flow (OCF − capex)$86.0M

Margins

Q3 2026Q3 2025Change
Gross margin21.1%21.5%-0.5 pts
Operating margin7.7%-52.7%+60.5 pts
Net margin2.9%-56.1%+59.0 pts
Free cash flow margin18.3%15.8%+2.5 pts

Every line

LineQ3 2026Q3 2025Change%
Engineered Materials$1.4B$1.4B−$16.0M-1%
Acetyl Chain$1.2B$1.0B$153M+15%
Revenue$2.6B$2.4B$137M+6%
Gross profit$539M$521M$18.0M+3%
Cost of revenue$2.0B$1.9B$119M+6%
Operating profit$198M−$1.3B$1.5B—
Operating expenses$341M$1.8B−$1.5B-81%
Pre-tax earnings$92.0M−$1.4B$1.5B—
Other expense, net$106M$85.0M$21.0M+25%
Research & development$29.0M$31.0M−$2.0M-6%
SG&A$248M$231M$17.0M+7%
Other operating costs$64.0M$1.5B−$1.5B-96%
Net earnings$74.0M−$1.4B$1.4B—
Minority interests$4.0M$4.0M$00%
Income tax$14.0M−$7.0M$21.0M—
Depreciation & amortization$216M$201M$15.0M+7%
Share-based compensation$8.0M$7.0M$1.0M+14%
Working capital & other$240M$1.6B−$1.4B-85%
Operating cash flow$538M$447M$91.0M+20%
Free cash flow (OCF − capex)$469M$383M$86.0M+22%
Capital expenditures$69.0M$64.0M$5.0M+8%

Questions

How much did Celanese's revenue grow year over year in Q3 2026?

Celanese's revenue rose $137M (+6%) from $2.4B in Q3 2025 to $2.6B in Q3 2026.

What drove Celanese's revenue change in Q3 2026?

Acetyl Chain +$153M (+15%); Engineered Materials −$16.0M (-1%).

Q3 2026 results → · Compare in the interactive Sankey →